NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (OTCQB: RTRX) today announced that it will provide funding, over a three-year term, to The Hospital for Sick Children (“SickKids®”), Canada’s largest pediatric academic health sciences center, in support of its study entitled, “Carrier Mediated Delivery of Therapeutic Proteins into the Brain.” The Company’s funding to SickKids will be matched by Brain Canada, as part of a Multi-Investigator Research Initiative Grant.
Help employers find you! Check out all the jobs and post your resume.
